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BACKGROUND & AIMS: The phenotypic and func-
tional characteristics of natural killer (NK) cells in
chronic hepatitis B virus (HBV) and hepatitis C virus
(HCV) infections are incompletely defined and largely
controversial. METHODS: We studied NK cell receptor
expression, cytotoxic activity, and cytokine production in
peripheral blood mononuclear cells from 35 patients
with chronic hepatitis C, 22 with chronic hepatitis B, and
30 healthy controls. RESULTS: Patients with chronic
HBV infection had an increased proportion of NKG2C!
NK cells with normal inhibitory receptor expression and
a lower proportion of activated NK cells compared with
HCV! patients, which was associated with normal or
reduced cytolytic activity and markedly dysfunctional
tumor necrosis factor-! and interferon-" production.
Patients with chronic HCV infection showed a predom-
inantly activating phenotype, featuring a decreased
percentage of cells expressing the inhibitory receptor
KIR3DL1 and a concomitant increase in the proportion of
NKG2D! NK cells. Expression of the CD69 early activa-
tion antigen on NK cells positively correlated with serum
alanine aminotransferase and HCV RNA values, suggest-
ing participation of virus-induced effector NK cells in
liver necroinflammation. Phenotypic changes in HCV!
patients were associated with enhanced cytokine-induced
cytolytic activity and increased usage of natural cytotox-
icity and NKG2D receptor pathways, accompanied by
defective cytokine production, although to a lesser extent
than patients with chronic HBV infection. CONCLU-
SIONS: These findings provide evidence for a func-
tional dichotomy in patients with chronic HBV and
HCV infections, featuring conserved or enhanced cy-
tolytic activity and dysfunctional cytokine produc-
tion, which may contribute to virus persistence.
Studies on early immune defense mechanisms showedthat hepatitis B virus (HBV) infection does not in-
duce appreciable changes in innate immune response
genes in the first weeks of infection, whereas hepatitis C
virus (HCV) efficiently induces interferon (IFN)!/#-
response genes.1 However, available evidence suggests
that HCV eludes innate cellular defense mechanisms by
blocking IFN-signaling pathways.2–5 Interestingly, de-
spite the apparent silence of IFN!/# response genes in
HBV-infected chimpanzees, there is evidence of natural
killer T (NKT) cell activation in the transgenic mouse
model of HBV infection, which can inhibit virus replica-
tion via IFN-" production,6 and, in addition, NKT cells
can be triggered during HBV infection by the expression
of stress signals on infected hepatocytes recognized by
natural killer cell receptors (NKRs).7
NK cells are important antiviral effectors of innate
immunity because of their contribution to virus elimina-
tion via direct killing of infected cells and cytokine
(IFN-" and tumor necrosis factor [TNF]-!) production,
and their regulation depends on a fine balance between
inhibitory and activating receptors (NKRs).8–10 Preferen-
tial expression of the inhibitory receptor KIR2DL3 on
NK cells has been reported in patients with a self-limited
outcome of acute HCV infection acquired by a low-dose
exposure.11 However, the real impact of these mecha-
nisms on NK cell function is unknown because pheno-
typic changes do not necessarily reflect altered func-
tion.12,13 The observations that the interaction of the E2
protein of HCV with CD81 on NK cells inhibits their
activation14,15 and that NK cell functions can be deficient
in individuals chronically infected with HCV16–29 suggest
that HCV may actually contribute to impair the NK cell
response, although the data are still controversial.20
In the present study, we have performed an extended
phenotypic analysis of peripheral blood NK cells in
chronic HBV and HCV infections by determining activat-
ing and inhibitory NKR expression. In addition, we ex-
amined NK cytolytic potential and cytokine production
in the presence or absence of cytokine stimulation. We
Abbreviations used in this paper: HBV, hepatitis B virus; HCV, hep-
atitis C virus; ICS, intracellular staining; IFN-!, interferon !; mAbs,
monoclonal antibodies; MICA-B, major histocompatibility complex
class I-chain related proteins A and B; NCR, natural cytotoxicity recep-
tor; NK, natural killer; NKR, natural killer receptor; NKT, natural killer T;
PBMC, peripheral blood mononuclear cells; RAE-1, retinoic acid early
inducible protein 1; TNF-", tumour necrosis factor ".
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show that NK cells from patients with chronic HBV and
chronic HCV infections differ in NKR expression and
that NK function is characterized by a conserved or
enhanced cytolytic activity and a dysfunctional cytokine
production. This defect may be an important mechanism
contributing to virus persistence.
Materials and Methods
Isolation and Storage of Peripheral Blood
Mononuclear Cells
Twenty milliliters of venous blood was drawn
from 35 consecutive untreated patients with chronic
HCV infection, 22 with chronic HBV infection, and 30
healthy donors. Informed consent in writing was ob-
tained from each individual. The study protocol con-
formed to the ethical guidelines of the 1975 Declaration
of Helsinki and was approved by the Institutional Review
Board and Ethical Committee of Fondazione I.R.C.C.S.
Policlinico San Matteo. The characteristics of HBV-posi-
tive and HCV-positive patients are listed as Supplemen-
tary Table 1. Peripheral blood mononuclear cells (PBMC)
were isolated by standard Ficoll-Isopaque density gradi-
ent centrifugation (Lympho Separation Medium, MP
Biomedicals, OH) and stored in liquid nitrogen.
Cell Surface Staining and Flow Cytometry
Analysis
NKR phenotype was carried out as previously de-
scribed.21 NK cells were identified in PBMC as CD3"/
CD20"/CD56! and could be easily defined as CD56dim
and CD56bright according to fluorescence intensity. Ex-
pression of several activating (NKG2D, CD94/NKG2C,
NKp44, NKp46, and NKp30) and inhibitory (IRP60,
CD94/NKG2A, KIR2DL1, KIR2DL2, KIR3DL1, LIR1/
ILT2, p75/AIRM1) NKRs, as well as coreceptors (2B4,
NTB-A, NKp80, DNAM.1) and early activation molecules
(CD69) was examined by labelling with monoclonal an-
tibodies (mAbs) as described previously.21 In addition, a
detailed analysis of single inhibitory receptor expression
was carried out using PE-conjugated IgG1 mAbs specific
for KIR2DL2/DL3/DS2 (CD158 b1,b2,j), KIR2DL1/DS1
(CD158 a,h), KIR3DL1/DS1 (Z27, CD158 e1,e2), and
ILT2 (CD85), all from Beckman Coulter, Fullerton, CA.
Flow cytometry analysis was performed using a 2 laser
FACSCalibur instrument equipped with CellQuest Pro
software (BD Bioscience).
Cytokine Production by Intracellular Staining
Intracellular staining (ICS) was carried out as de-
scribed elsewhere,22 with minor modifications. TNF-!
and IFN-" production by NK cells was tested by ICS after
overnight stimulation of PBMC with different combina-
tions of cytokines: interleukin (IL)-2 (100 U/mL; Bio-
source, Camarillo, CA)! IL-12 (0.5 ng/mL; R&D System,
Minneapolis, MN) and IL-2 (100 U/mL) ! IL-21 (100
ng/mL; Biosource). IL-21 was used in cytokine combina-
tions because it was shown to efficiently stimulate IFN-"
production by NK cells23,24 and was as effective or more
than IL-15 in stimulating CD107a degranulation and
cytokine production as shown by preliminary experi-
ments (Supplementary Figure 1A–D). After stimulation,
PBMCs were plated at 2 # 105 cells/well with GolgiStop
solution (BD Biosciences, San Jose, CA) in 96 well flat
bottom plates coated with 10 $g/mL anti-CD16 (Fc"RIII)
IgM antibody (Immunological Sciences, Rome, Italy).
CD16 engagement on CD56bright cells is a secondary
signal required for IFN-" production,25 and CD16 ex-
pression on these cells was shown to increase 3- to
4-fold following stimulation with the cytokine combi-
nations employed in this study (Supplementary Figure
2). Unstimulated PBMCs and uncoated plates served as
negative controls. After 4-hour incubation at 37°C,
cells were harvested, washed with phosphate-buffered
saline (PBS) 2% fetal bovin serum (FBS), and stained
for 30 minutes at 4°C with directly conjugated anti-
CD56 PC5, anti-CD19 PE, and anti-CD3 FITC antibodies.
Next, PBMCs were washed, fixed, and permeabilized by BD
Cytofix/Cytoperm Solution (BD Biosciences) according to
the manufacturer’s instructions and stained with anti-
IFN-" or anti-TNF-! allophycocyanin (APC)-conjugated an-
tibodies (BD Biosciences).
CD107a Degranulation Assay
CD107a degranulation assay was performed
as described,26 with minor modifications. Although
CD107a degranulation is an indirect measure of cytotox-
icity, it is now widely used to assess the cytotoxic poten-
tial of CD8! T cells and NK cells,27 and it has been shown
that there is a linear correlation between data obtained
with the traditional 51Cr release assay and the CD107a
degranulation assay.28 Briefly, after a 72-hour stimula-
tion with different combinations of cytokines (IL-2!
IL-12 and IL-2!IL-21), PBMCs were washed and incu-
bated for 3 hours at 37°C with K562 or P815 target cells
(E:T$1:1) in the presence of anti-CD107a PE antibody.
Lytic activity was determined by flow cytometry and ex-
pressed as percentage of CD107a!/CD56!/CD3" NK.
Moreover, redirected cytotoxicity experiments were set up
in which PBMCs were cultured with Fc"R! P815 target
cells, with or without mAb specific for the natural cyto-
toxicity receptors (NCRs) NKp30 and NKp46 and for
NKG2D.29 The latter approach allows binding of the
mAb to P815 target cells via the immunoglobulin Fc"
receptor and at the same time triggering of the lytic
process through binding to the activating receptor ex-
pressed on effector cells. As for ICS, IL-21 was used in
cytokine combinations because it was shown to augment
NK cell proliferation and cytolytic activity.23,24 Original
data illustrating positive and negative controls of the
CD107a degranulation assay are included as Supplemen-
tary Figure 3.
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Statistical Analysis
The nonparametric Mann-Whitney U test was
used to compare data, which were not normally distrib-
uted, between the different groups. Phenotypic and func-
tional data are expressed as median percentage, 95% con-
fidence interval (CI). Correlations between variables were
analyzed using the Pearson correlation coefficient (r). A
P value % .05 was deemed statistically significant.
Results
Peripheral Blood NK Cell Subsets in Patients
With Chronic HBV and HCV Infections
The proportion of circulating NK cells was signif-
icantly lower in HCV! and HBV! patients compared with
healthy subjects (Figure 1A). The frequency of NK cells
expressing the NKG2C activating receptor was signifi-
cantly higher in HBV-positive patients compared with
HCV! patients and healthy subjects (Figure 1B), whereas
the frequency of NK cells expressing the NKG2D activat-
ing receptor was significantly increased in HCV! patients
compared with healthy controls (Figure 1C). Dot plots
reporting staining with NKG2D-specific mAb and an
isotype control in representative subjects are shown as
Supplementary Figure 4. The frequency of CD69!-acti-
vated NK cells was higher in HCV! patients compared
with HBV! patients (P$ .044), even though both patient
groups failed to show statistically significant differences
with healthy subjects (Figure 1D). The observations
showing increased proportions of NK cells expressing
activation markers were supported by data on mean flu-
orescence intensity per cell, which was also increased
(Supplementary Figure 5A–C). Conversely, the propor-
tion of NK cells expressing inhibitory receptors (INKRs),
identified by a pool of monoclonal antibodies directed
against KIR2DL1, KIR2DL2, KIR3DL1, and LIR1/ILT2,
was significantly reduced in HCV! but not in HBV!
patients compared with controls (Figure 1E). To identify
which of the inhibitory receptor(s) was expressed at a
lower level in patients with chronic HCV infection, we
studied 17 patients with chronic HBV infection, 21 with
chronic HCV infection, and 20 healthy donors, using
single-receptor specific mAbs as detailed above. There was
a statistically significant decrease in the proportion of
KIR3DL1/DS1-expressing NK cells both in HCV- and
HBV-infected patients (Figure 2A). However, when the
activating KIR3DS1 allele-expressing NK cells (defined as
the dim fraction of CD158 e1,e2 positive cells identified
by mAb Z27, Figure 2B) were subtracted from analysis,
the reduction remained significant in HCV-infected pa-
tients only (Figure 2C). Expression of the other inhibitory
Figure 1. Frequencies and phenotype of circulating NK cells are significantly reduced in both HCV! and HBV! patients compared with healthy
donors (A). Increased proportion of NKG2C! NK cells in HBV! patients (B), and of NKG2D! NK cells in HCV! patients (C), compared to HD. The
proportion of activated (CD69!) NK cells is higher in HCV! patients compared with HBV! patients but not significantly so compared with healthy
donors (D). Reduced proportion of NK cells expressing a broad range of inhibitory receptors (INKRs) identified by a pool of mAbs (E). HD, healthy
controls (empty bars);HCV, patients with chronic HCV infection (solid light grey bars);HBV, patients with chronic HBV infection (solid dark grey bars).
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receptors did not differ from healthy donors (Figure
2D–F).
NKR expression on the CD56dim NK cell subset broadly
mirrored the differences between groups observed with
the total NK cell population (Supplementary Figure 6A–
E). However, when the CD56bright subset was considered
for analysis, a statistically significant difference was only
observed in the proportion of NKG2D! cells, which,
similarly to CD56dim, was lower in HBV! compared with
HCV! patients and in the proportion of NK cells express-
ing inhibitory receptors (data not shown).
NK Cytolytic Activity in Patients With
Chronic HBV and HCV Infections
No statistically significant differences in the
CD107a degranulation assay were observed using K562
target cells between healthy subjects and HBV- or HCV-
positive patients in the absence of cytokine stimuli (data
not shown). However, following stimulation with both
combinations of cytokines, significantly decreased cyto-
toxicity compared with healthy donors was seen in HBV!
patients only (P $ .01 and P $ .019, after stimulation
with IL-2!IL-12 and IL-2!IL-21, respectively; Supple-
mentary Figure 7). Spontaneous cytotoxicity for P815
target cells in the absence of cytokines or triggering
antibodies was significantly higher than healthy controls
in HCV! patients and to a much lesser extent in HBV!
subjects, which in both cases was restricted to the
CD56dim subset (Figure 3A). Stimulation with combina-
tions of cytokines led to a statistically significant increase
in cytolytic activity only in HCV! patients compared with
healthy subjects who showed levels of lytic activity com-
parable with HBV! patients (Figure 3B). Representative
original data are shown in Figure 3C. Redirected cytotox-
icity experiments are shown on Figure 4. Significantly
increased degranulation was observed using anti-NKG2D
and anti-NKp46 mAbs in both HCV! and HBV! patients,
which again was exclusively restricted to the CD56dim
subset using anti-NKG2D mAb (Figure 4A). In HCV!
patients increased lytic activity was extended to CD56bright
NK cells using NKp46- and NKp30-specific mAbs, respec-
Figure 2. Single inhibitory receptor analysis shows that KIR3DL1 is significantly less expressed on NK cells from HCV-positive patients. Panels A
and C and D–F show cumulative data from all patients tested for the specific molecules indicated in the panels; the vertical axis represents the
percentage of positive cells. Panel B reports differential expression of the KIR3DL1 and KIR3DS1 alleles using mAb Z27 on three representative
patients: one KIR3DL1 homozygote (top), one KIR3DL1/DS1 heterozygote (middle), and one KIR3DS1 homozygote (bottom). KIR3DL1 allele-
expressing NK cells appear as the bright fraction, and KIR3DS1 allele-expressing NK cells appear as the dim fraction at flow cytometry with mAb Z27.
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tively (Figure 4B and C). Cytokine stimulation with IL-
2!IL-12 produced a nonsignificant increase in cytotox-
icity in HCV! patients using NKp30 and NKp46 mAbs
compared with healthy donors; however, following addi-
tion of IL-2!IL-21, the increment reached statistical sig-
nificance (Figure 5A and B). NCR expression was similar
in all patient categories (Supplementary Figure 8), and
there was no correlation between the proportion of NCR-
expressing cells and redirected cytotoxicity using NCRs
as triggering antibodies (not shown). Redirected cytotox-
icity with anti-NKG2D mAb produced increased NK lytic
activity using both cytokine combinations, which was
restricted to the HCV! patient group (Figure 5C). NK
lytic activity in HBV! patients was always comparable
with that of healthy subjects, consistently and signifi-
cantly lower than in HCV! patients (Figure 5A–C).
Differential analysis of the CD56bright and CD56dim
subsets proved impossible after cytokine stimulation
(not shown).
NK Cell Cytokine Production in Patients
With Chronic HCV and HBV Infections
Patients with chronic HBV infection displayed
significantly lower IFN-" and TNF-! production com-
pared with healthy controls in all experimental condi-
tions (Figure 6A–D). This was remarkably reproducible
irrespective of the combination of cytokines used as stim-
ulus and was evident in both CD56dim and CD56bright
subsets. Patients with chronic HCV infection also showed
reduced cytokine production, albeit to a lower extent
than HBV! patients. Indeed, IL-2!IL-12-stimulated NK
Figure 4. Redirected NK degranulation assay with P815 target cells
using anti-NKG2D (A), anti-NKp46 (B), and anti-NKp30 (C) mAbs with-
out cytokine stimulation. HD, healthy controls (empty bars); HCV, pa-
tients with chronic HCV infection (solid light grey bars); HBV, patients
with chronic HBV infection (solid dark grey bars).
Figure 3. Spontaneous NK cytotoxicity for P815 target cells is signif-
icantly increased in patients with chronic HBV and HCV infections and is
restricted to the CD56dim subset (A). Stimulation of NK cells with com-
binations of cytokines (IL-2!IL-12 or IL-2!IL-21) led to a statistically
significant increase only in patients with chronic HCV infection (B). Panel
C shows a representative density plot of a patient with chronic HCV
infection demonstrating significantly higher percentage of CD107a!NK
cells compared with healthy donors following cytokine stimulation. HD,
healthy controls (empty bars); HCV, patients with chronic HCV infection
(solid light grey bars); HBV, patients with chronic HBV infection (solid
dark grey bars).
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cells induced generally lower, although not significantly
diminished, cytokine production except in the CD56bright
subset in which a statistically reduced TNF-! production
was demonstrated (Figure 6A and B). However, when
IL-2!IL-21 were used as stimulus, there was a statisti-
cally significant decrease in IFN-" and TNF-! production
also in HCV! patients, which was restricted to the
CD56dim subset (Figure 6C and D).
Biochemical, Histologic, and Virologic
Correlates of NK Phenotype and Function
Several possible statistical correlations were
sought between phenotype and function of NK cells,
and biochemical (serum ALT, "-glutamil transpepti-
dase, "-globulin), or virologic (HCV genotype, serum
HCV RNA or HBV DNA levels) indicators. In patients
with chronic HCV infection, there was a statistically
significant positive correlation between the proportion
of activated (CD69!) NK cells and serum alanine amino-
transferase (ALT) as a surrogate marker of liver necroin-
flammation (Figure 7A), which was limited to the
CD56dim subset (Pearson, r $ 0.43; P $ .02). Also, there
was a positive correlation between activated NK cells and
serum HCV RNA values (Figure 7B), which was limited to
Figure 6. Production of IFN-" and TNF-! by circulating NK cells is
consistently and significantly reduced in patients with chronic HBV in-
fection and, to a lesser extent, also in patients with chronic HCV infec-
tion. Cytokine production following stimulation with IL-2!IL-12 (A,B);
cytokine production following stimulation with IL-2!IL-21 (C,D). HD,
healthy controls (empty bars); HCV, patients with chronic HCV infection
(solid light grey bars); HBV, patients with chronic HBV infection (solid
dark grey bars).
Figure 5. Redirected NK degranulation assay with P815 target cells
using anti-NKp30 (A), anti-NKp46 (B), and anti-NKG2D (C) mAbs fol-
lowing cytokine stimulation (IL-2!IL-12 or IL-2!IL-21). Patients with
chronic HBV infection display consistently lower NK cell lytic activity
than patients with chronic HCV infection, who instead show significantly
higher lytic activity also compared with healthy donors. HD, healthy
controls (empty bars); HCV, patients with chronic HCV infection (solid
light grey bars); HBV, patients with chronic HBV infection (solid dark
grey bars).
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the CD56bright subset (Pearson, r $ 0.56; P $ .003).
Interestingly, there was a statistically significant negative
correlation between the proportion of NKG2D! NK cells
and ALT (Figure 7C). This NK subset appeared to con-
centrate in the liver as shown by findings indicating a
substantial enrichment of NKG2D-positive cells in the
intrahepatic compartment compared with the peripheral
blood (Figure 7D and E). There was a positive correlation
between frequencies of circulating and intrahepatic
NKG2D-positive NK cells (Pearson, r $ 0.51, P $ .04).
However, no direct correlation was found between total
populations of peripheral and intrahepatic NK cells (not
shown). No relevant statistical correlations were found with
functional data, eg, CD107a degranulation and cytokine
intracellular staining (not shown). Moreover, no correla-
tions were found in patients with chronic HBV infection
between NK phenotype and function and the indicators
listed above (not shown).
Discussion
NK cells are tightly regulated by signals through a
variety of stimulatory, costimulatory, and inhibitory re-
ceptors, which bind components of pathogens, host cells,
or cytokines.8–10 In this study, we analyzed the expression
of a large number of NK inhibitory and activating recep-
tors and showed that there exist profound differences in
NK cell phenotype and function between chronic HBV
and HCV infections. In the latter, there was an increased
proportion of NKG2D-expressing NK cells, which was
also supported by mean fluorescence intensity data, and
a concomitant decrease in those expressing inhibitory
receptors, supporting the concept of a phenotype skewed
toward activation, predominantly involving the NKG2D
pathway. Instead, in the former, there was an increased
proportion of NKG2C-expressing cells with normal in-
hibitory receptor expression, suggesting a more balanced
activating/inhibitory receptor expression. Although sin-
gle inhibitory receptor expression analysis clearly showed
significantly decreased proportions of KIR3DL1/DS1-
expressing NK cells in both HCV- and HBV-infected
patients, reduction of the inhibitory KIR3DL1 allele-
expressing cells was only seen in HCV-positive patients,
which identifies KIR3DL1/DS1 as a major candidate re-
ceptor involved in NK regulation in chronic HCV infec-
tion. Interestingly, KIR3DL1 has a long cytoplasmic tail
that permits inhibitory signalling, whereas KIR3DS1
lacks the immunoreceptor tyrosine-based inhibition mo-
tif as other activating receptors and effectively functions
as an activating receptor.30,31 KIR3DL1- and KIR3DS1-
expressing cells can be easily identified as they segregate
as different subsets of mAb Z27bright and Z27dim cells,
respectively.31 Expression of KIR3DS1 has been associ-
ated with delayed progression to AIDS and opportunistic
infections,32,33 lending further support to the notion that
it acts as activating receptor. Whether similar regulatory
mechanisms are implicated in the progression of chronic
hepatitis C requires further studies.
Figure 7. The proportion of activated (CD69!) NK cells positively correlates with serum ALT (panel A) and HCV RNA (panel B) levels in patients with
chronic HCV infection. Panel C shows a negative correlation between NKG2D! NK cells and ALT. Results are expressed as Pearson correlation
coefficients. Panel D illustrates a representative density plot in a HCV! patient showing proportions of NKG2D! NK cells from the peripheral blood
and the intrahepatic compartments, respectively. Panel E shows the proportions of NKG2D! NK cells and the corresponding NKG2D mean
fluorescence intensity in the peripheral blood and liver from 16 patients with chronic HCV infection. In this experiment, a small fragment of a diagnostic
liver biopsy specimenwasmechanically disrupted and digestedwith collagenase IV and DNAse. Viable intrahepatic mononuclear cells were analysed
by flow cytometry as described.21
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Differences in NKR expression were mirrored by clear
functional differences. Whereas reduced NK cell frequen-
cies did not affect spontaneous cytolytic effector function
in agreement with previous studies,12,13,34,35 NK cells
from HCV! patients responded well to cytokine stimu-
lation displaying normal or increased cytolytic activity
towards K562 and P815 target cells, respectively, at vari-
ance with data suggesting that HCV envelope proteins
impair NK cell activation and function14,15 and consis-
tent with recently published findings indicating that cul-
ture-derived infectious HCV particles do not affect NK
function.36 This was further confirmed in the redirected
cytotoxicity assay, which clearly showed that HCV infec-
tion is able to enhance NK cytotoxicity mainly through
the NKG2D pathway and that NCRs, such as NKp30 and
NKp46, are also involved despite apparently not being
expressed at levels higher than healthy donors. Instead,
patients with chronic HBV infection displayed normal or
even lower cytotoxic activity for P815 and K562 targets,
respectively, upon cytokine stimulation compared with
patients with chronic HCV infection and healthy sub-
jects, and, in keeping with this observation, redirected
killing was indistinguishable from healthy donors. In this
respect, our findings disagree with studies that showed
deficient NK cytolytic activity in HCV-infected sub-
jects14–19 but are in agreement with several others show-
ing conserved cytotoxic potential.12,13,34,35 The reasons
for such discrepancies are not immediately apparent,
although they may be due, in part, to clinical, biochem-
ical, and virologic heterogeneity of patients, for which we
have attempted to control by performing an extended
phenotypic and functional analysis in a substantial num-
ber of unselected patients and healthy donors.
The CD69 early activation antigen37 was expressed in a
higher proportion of NK cells from HCV! patients com-
pared with HBV! patients, possibly explaining differ-
ences in the effector cytotoxic potential observed in the 2
patient groups. Interestingly, in HCV! patients, the pro-
portion of CD69!/CD56dim NK cells correlated with se-
rum ALT, a surrogate marker of liver necroinflammation,
suggesting that mature activated NK cells are involved in
liver immunopathology in this setting. Moreover, the
direct correlation between serum HCV RNA levels and
CD69! NK (CD56bright) cells would be compatible with
the observation that HCV replication is responsible for
activation of this NK cell subset during chronic infection
as shown by others,13 although we were unable to con-
firm the reported increase in IFN-" production by these
cells.
The frequencies and phenotype of the CD56dim NK
cells and their degranulation capacity in the absence of
cytokine stimuli broadly reflected the results obtained
with the total NK cell population and emphasized their
propensity toward cytolytic function,8–10 although, in
HCV-infected patients, significant redirected cytotoxicity
could be documented also in the CD56bright subset. How-
ever, stimulation with cytokines conferred IFN-" and
TNF-! production ability to both subsets, suggesting
that the broadly accepted functional differences between
the 2 subsets may not be so rigid, at least in this in vitro
system.
The finding of a negative correlation between circulat-
ing NKG2D! NK cells and ALT in patients with chronic
HCV suggests homing of these cells to the liver where
they may exert effector cytotoxic function, as suppor-
ted by our preliminary findings demonstrating that
NKG2D! NK cells are highly enriched in the intrahepatic
compartment. NKG2D belongs to the II C-type lectin-
like family of transmembrane proteins and functions
both as an activating and costimulatory receptor serv-
ing a fundamental role in the surveillance against
microbial infections and cancer.38,39 The natural ligands
for NKG2D are major histocompatibility complex class I
chain-related proteins A and B (MICA and -B), which are
stress inducible, nonclassical class I molecules, both of
which can activate NK cells,40 and members of the reti-
noic acid early inducible RAE-1 protein family, some of
which were initially characterized as ligands for the CMV
UL16 protein.41 Interestingly, interaction of NKG2D
with RAE-1 on hepatocytes in a transgenic mouse model
of HBV infection was found to be an important recogni-
tion pathway of experimental NK cell-mediated liver in-
jury.42 However, expression of NKG2D ligands in the
healthy and diseased human liver is only partially known
in the case of MICA43 and notably lacking in the case of
RAE-1. Studies addressing this issue are currently in
progress in our laboratory.
While differences in the cytotoxic potential between
HBV! and HCV! patients were robust and reproducible,
IFN-" and TNF-! production following stimulation with
different cytokine combinations was shown to be dys-
functional also in HCV! patients, even though to a lesser
extent than in HBV! patients. Different cytokine com-
binations seemed to account for different responses.
Indeed, the presence of IL-21 proved to be a weaker
stimulus in combination with IL-2 compared with
IL-2!IL-12, which maintained IFN-" and TNF-! pro-
duction at a lower, although statistically comparable,
level than that of healthy donors.
Collectively, our data provide evidence for a functional
dichotomy in chronic HCV infection, with a clearly en-
hanced basal and cytokine-induced lytic activity and a
reduced TNF-! and IFN-" production, a functional de-
fect that was definitely more profound in the setting of
chronic HBV infection. The biologic consequences of
dysfunctional cytokine production in chronic hepatitis C
would be that HCV persists in the host in the face of an
enhanced NK cytotoxic activity. Indeed, IFN-" produc-
tion has been shown to be a powerful non-cytolytic
mechanism of viral clearance from infected hepato-
cytes,44 and it can specifically inhibit HCV replication in
vitro.45,46 Interestingly, IFN-" production by virus-spe-
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cific T cells is also significantly impaired during chronic
HCV infection,47,48 adding to the concomitant NK cell
defect we have demonstrated here. TNF-!, instead, ap-
pears to be inefficient in controlling HCV replication as
shown in replicon-containing hepatoma cells compared
with IFN-",49 but it seems to be a key mediator in HBV
persistence because of its direct antiviral effect44 and
because it is essential for the proliferation of HBV-spe-
cific cytotoxic T cells.50 Moreover, patients treated with
TNF-! inhibitors may incur a severe reactivation of
chronic hepatitis B, adding further evidence in support of
the importance of this cytokine in HBV control.51 The
markedly defective NK cytokine production in the con-
text of a relatively normal or reduced (in the case of K562
target cells) NK cytolytic activity only in HBV infection
presumably reflects the poor cellular response to type I
IFN-inducible genes in this condition1 and suggests that
the previously reported mechanism of cytokine-induced
tumor necrosis factor-related apoptosis-inducing li-
gand (TRAIL)-mediated NK cell killing of hepatocytes
probably occurs predominantly during liver inflamma-
tory flares,52 which are typically observed in this set-
ting.53
In conclusion, our study revealed previously unappre-
ciated findings in patients with chronic HBV and HCV
infections, featuring conserved or enhanced cytolytic ac-
tivity and dysfunctional cytokine production, which may
be a key factor contributing to virus persistence and
chronic liver immunopathology.
Supplementary Data
Note: To access the supplementary material
accompanying this article, visit the online version of
Gastroenterology at www.gastrojournal.org, and at doi:
10.1053/j.gastro.2009.05.047.
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Supplementary Table 1. Characteristics of Patients Studied
HCV HBV
Number 35 22
Sex: M/F 14/21 13/9
Age, y, median (range) 54 (18"71) 48 (20"72)
ALT, U/mL, median (range) 43 (12"141) 50.5 (13"291)
Viral load, IU/mL, median (range) 1.17 # 106 (0.015"5.77 # 106) 1.48 # 105 (17 # 101"1.1 # 108)
Viral genotypea Yes ND
1 18
2 12
3 2
4 1
NOTE. Serum HCV RNA levels were determined by quantitative Versant HCV RNA 3.0 bDNA assay (Bayer Diagnostics, Berkeley, CA: lower limit
of detection 600 IU/mL). Serum HBV DNA values were determined by an in-house real-time quantitative PCR using primers of the polymerase
region with a lower limit of detection of 5 IU/mL.
ND, not determined.
aGenotype was not performed in 2 patients with chronic HCV infection.
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Supplementary Figure 1. Interleukin (IL)-21 is more effective than IL-15 in stimulating CD107a degranulation (A and B) in a redirected cytotoxicity
assay and as effective as IL-15 in cytokine production (C and D). Details of CD107a degranulation assay and intracellular staining are reported in
Materials and Methods section. NS, data without cytokine stimulus; IL-15, data after stimulation with IL-15; IL-2!IL-21, data after stimulation with
IL-2!IL-21.
Supplementary Figure 2. Cytokine stimulation induces a 3- to 4-fold increase in CD16 expression on CD56bright natural killer (NK) cells. Expression
of CD16 was examined on CD56!/CD3" cells without prior stimulation or after stimulation with the indicated cytokine combinations. Data are shown
as contour plots, and percentages of gated cells are reported as appropriate.
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Supplementary Figure 3. Density plots of CD107a degranulation assays reporting representative original data of a redirected cytotoxicity
experiment in a patient with chronic HCV infection. Letter A refers to data obtained in the absence of cytokine stimuli; letters B and C report data
obtained after stimulation with IL-2!IL-12 and IL-2!IL-21, respectively. Target cells were P815. Experimental conditions were as listed in the Figure:
Effectors alone, effector cells without target cells; E!T, effector cells with target cells; E!T!control IgG, effector cells with target cells and isotype
control; E!T!anti-NKG2D, effector cells with target cells and NKG2D-specific mAb; E!T!anti-NKp30, effector cells with target cells and NKp30-
specific mAb. Anti-NKp30 was used as positive control because it reproducibly induced strong degranulation in the redirected cytotoxicity assay.
Details of the degranulation assay are reported in Materials and Methods section.
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Supplementary Figure 4. Expression of NKG2D on peripheral blood NK cells from a healthy donor (A–C) and an HCV-positive patient (D–F). Data
are shown as pseudocolor dot plots (with the percentages of gated NK cells) and histograms using an IgG isotype control and an NKG2D-specific
mAb as reported in Materials and Methods section.
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Supplementary Figure 5. Mean fluorescence intensity (MFI) of NK
cell activation markers mirrors data on percentage of NK cells express-
ing these molecules. A, CD69; B, NKG2D; C, NKG2C. HD, healthy
controls (empty bars); HCV, patients with chronic HCV infection (solid
light grey bars); HBV, patients with chronic HBV infection (hatched
bars).
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Supplementary Figure 6. Frequencies and phenotype of circulating CD56dim NK cells in patients with chronic HBV and HCV infections.
Frequencies of peripheral blood NK cells are significantly reduced in HCV! patients compared with healthy donors (A). Increased proportion of
NKG2C! NK cells in HBV! patients (B) and of NKG2D! NK cells in HCV! patients but only when compared with HBV! patients (C), which is
associated with a reduced proportion of NK cells expressing inhibitory receptors (INKRs) (D) identified by a pool of mAbs, as described in Materials
and Methods section. The proportion of activated (CD69!) NK cells is significantly higher in HCV! patients compared with healthy donors and HBV!
patients (E). HD, healthy controls (empty bars); HCV, patients with chronic HCV infection (solid light grey bars); HBV, patients with chronic HBV
infection (hatched bars).
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Supplementary Figure 7. Cytokine-induced NK cytolytic activity for
K562 target cells is significantly reduced in patients with chronic HBV
infection. PBMC were stimulated with combinations of cytokines (IL-
2!IL-12 or IL-2!IL-21), and cytotoxicity was examined by the CD107a
degranulation assay.
Supplementary Figure 8. Natural cytotoxicity receptors (NCRs) are
expressed at equal intensity on NK cells from all subject categories.
NKp30, NKp44, and NKp46 were stained on PBMC with monoclonal
antibodies as described in Materials andMethods section and analyzed
by flow cytometry. Data are expressed as mean fluorescence intensity
(MFI).
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